Literature DB >> 17292506

Gestational diabetes mellitus manifests in all trimesters of pregnancy.

V Seshiah1, V Balaji, Madhuri S Balaji, A Paneerselvam, T Arthi, M Thamizharasi, Manjula Datta.   

Abstract

Screening for GDM is usually performed around 24-28 weeks of gestational age. We undertook a study to estimate the prevalence of glucose intolerance during different trimesters, as data in this aspect is sparse. A total of 4151 consecutive pregnant women irrespective of gestational weeks attending antenatal health posts across Chennai city underwent a 75 g OGTT recommended by WHO and diagnosed GDM if 2 hr PG value > or =140 mg/dl. Women who had normal OGTT at the first visit were screened with a repeat OGTT at the subsequent visits. Among the screened, 741 women (17.9%) had 2 hr PG> or =140 mg/dl and were identified to have gestational diabetes. Analysis based on gestational weeks revealed that out of the 741 GDM women, 121 (16.3%) were within 16 weeks, 166 (22.4%) were between 17 and 23 weeks and 454 (61.3%) were more than 24 weeks of gestation. Observation in this study was that 38.7% developed gestational diabetes even prior to 24th week of gestation. Out of the total 741 GDM women, 214 (28.9%) were diagnosed on repeat testing at subsequent visits. Glucose intolerance occurs in the early weeks of gestation. Women who had normal glucose tolerance in the first visit require repeat OGTT in the subsequent visits.

Entities:  

Mesh:

Year:  2007        PMID: 17292506     DOI: 10.1016/j.diabres.2007.01.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  19 in total

Review 1.  Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence.

Authors:  Chun-Heng Kuo; Hung-Yuan Li
Journal:  Curr Diab Rep       Date:  2019-12-04       Impact factor: 4.810

2.  Global burden of early pregnancy gestational diabetes mellitus (eGDM): A systematic review.

Authors:  Wesley Hannah; Balaji Bhavadharini; Hannah Beks; Mohan Deepa; Ranjit Mohan Anjana; Ram Uma; Erik Martin; Kevin McNamara; Vincent Versace; Ponnusamy Saravanan; Viswanathan Mohan
Journal:  Acta Diabetol       Date:  2021-11-07       Impact factor: 4.280

Review 3.  Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand.

Authors:  P Reddi Rani; Jasmina Begum
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 4.  Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis.

Authors:  Katherine T Li; Shilpa Naik; Mallika Alexander; Jyoti S Mathad
Journal:  Acta Diabetol       Date:  2018-03-26       Impact factor: 4.280

Review 5.  Placental structural abnormalities in gestational diabetes and when they develop: A scoping review.

Authors:  Erin Ehlers; Omonseigho O Talton; Danny J Schust; Laura C Schulz
Journal:  Placenta       Date:  2021-04-26       Impact factor: 3.287

6.  Need for testing glucose tolerance in the early weeks of pregnancy.

Authors:  Seshiah Veeraswamy; Hema Divakar; Sanjay Gupte; Manjula Datta; Anil Kapur; Balaji Vijayam
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

7.  Quantitative analysis of key periodontopathic bacteria in gestational diabetic and non-diabetic women.

Authors:  Kavitha Ganiger; Srirangarajan Sridharan; Aparna Rahul; Aparna Satyanarayana
Journal:  J Diabetes Metab Disord       Date:  2019-06-27

Review 8.  Trends in the Diagnosis of Gestational Diabetes Mellitus.

Authors:  Surabhi Mishra; Chythra R Rao; Avinash Shetty
Journal:  Scientifica (Cairo)       Date:  2016-04-12

9.  Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India.

Authors:  Karoline Kragelund Nielsen; Peter Damm; Anil Kapur; Vijayam Balaji; Madhuri S Balaji; Veerasamy Seshiah; Ib C Bygbjerg
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

10.  Expression of intercellular adhesion molecule-1 in umbilical vascular of pregnant women with gestational diabetes mellitus and the clinical significance.

Authors:  Fei Teng; Jinfang Wu; Min Wei; Yongxiu Yang
Journal:  Exp Ther Med       Date:  2017-11-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.